Kestra Medical Technologies makes the ASSURE wearable defibrillator and a connected monitoring platform for heart patients. It last closed at $28.27 on Nov 17, up 1.07% on the day. KMTS reports earnings on Thu, Dec 10, 2026.
Only 1 firm rated KMTS in the past 90 days, not enough for a consensus
Average 12-month target
$32.00
▲ 13.2% upside
Based on 1 analyst who set a price target on KMTS in the past 90 days. The average target is $32.00, with a high of $32.00 and a low of $32.00, compared with the last close of $28.27.
Low $32.00Avg $32.00High $32.00
Blue marker: last close $28.27
Highest target$32.00
Average target$32.00
Lowest target$32.00
Latest rating changes
BTIGReiterated
Sep 2Buy$32
JP MorganInitiated
Aug 10Buy$30
Date
Firm
Action
Rating
Price target
Sep 2
BTIG
Reiterated
Buy
$32
Aug 10
JP Morgan
Initiated
Buy
$30
Loading…
Technical Analysis
KMTS · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 15% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 48). The nearest support is the Pivot at $28.16, and the nearest resistance the Pivot R1 at $28.72.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.4%/day
Key levels
$31.9852 week high+13.1%
$29.2720 day average+3.5%
$28.75Swing high (Aug 11)+1.7%
$28.72Pivot R1+1.6%
$28.27Last close
$28.16Pivot−0.4%
$27.90Swing low (Nov 5)−1.3%
$27.71Pivot S1−2.0%
$27.4950 day average−2.8%
$26.49100 day average−6.3%
$24.11200 day average−14.7%
$17.3452 week low−38.7%
Indicators
RSI (14)
48.29
Middle of its range
Neutral
MACD
0.30
Below its signal line
Bearish
Stochastic
14.0
Near the bottom of its range
Oversold
ADX (14)
17.6
No clear trend
Williams %R
-84.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-103.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−2.5%
Change over 10 sessions
Bearish
ATR (14)
$1.80
Typical daily range, 6.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityLow, 11.6%/day
Key levels
$31.9852 week high+13.1%
$29.2720 day average+3.5%
$28.75Swing high (Aug 11)+1.7%
$28.72Pivot R1+1.6%
$28.27Last close
$28.16Pivot−0.4%
$27.90Swing low (Nov 5)−1.3%
$27.71Pivot S1−2.0%
$27.4950 day average−2.8%
$26.49100 day average−6.3%
$24.11200 day average−14.7%
$17.3452 week low−38.7%
Indicators
RSI (14)
57.14
Middle of its range
Neutral
MACD
1.45
Above its signal line
Bullish
Stochastic
67.4
Middle of its range
Neutral
ADX (14)
11.8
No clear trend
Williams %R
-35.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
64.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+23.7%
Change over 10 sessions
Bullish
ATR (14)
$3.28
Typical daily range, 11.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100–
MA 200–
What happened before, for KMTS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how KMTS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in KMTS in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KMTS is in one of them and how their past KMTS trades turned out.
Kestra Medical Technologies is a medical device and digital health company based in Kirkland, Washington. It makes the ASSURE wearable cardioverter defibrillator, which is worn by patients at elevated risk of sudden cardiac arrest during recovery from heart problems. The company also offers a connected platform with a patient app, remote monitoring software for clinicians, and alert services that notify care teams when a shock is delivered. Its customers are patients and the healthcare providers who manage their cardiac care in the United States.